News Archives - Page 355 of 756

TuesdayJan 25, 2022 1:00 pm

Microdose Psychedelic Insights to Host Psychedelic Capital Conference

Microdose Psychedelic Insights is a cutting-edge media firm that aims to bring the psychedelics sector to the forefront of contemporary medicine by developing appealing content, disseminating financial analyses, and holding interesting industry events. On January 27, 2022, Microdose will host the Psychedelic Capital January Edition. Attendees will have access to the top firms, most recent IPOs, newest opportunities, and most in-depth market knowledge in the rapidly rising psychedelic medicine sector at the virtual event. Key Points CoveredThis month's conference features dynamic presentations from Heroic Hearts Project, Entheo Digital, PurMinds NeuroPharma, HAVN Life Sciences Inc. and panel discussions on topics of…

TuesdayJan 25, 2022 12:48 pm

Much Maligned Uranium Could Save the Planet

Freakish Midwest tornados, devastating wildfires, extreme droughts, abnormal floods – all signal the onset of a changing global climate. There’s overwhelming concern about climate change, but it’s difficult to achieve consensus on actions to mitigate it. The COP 26 UN Climate Change Conference last November was a step in the right direction, spurring global commitments and serving a clear notice that the era of coal is rapidly coming to an end. Three dozen countries, including the United States, pledged to stop funding fossil fuel projects abroad by the end of this year, and more than 40 countries promised to phase out…

TuesdayJan 25, 2022 12:06 pm

Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) Reports Findings of Commissioned Study Showing a Majority of Affected Americans Approve of Psychedelics as an Alternative Treatment for Select Mental Conditions

The Harris Poll conducted a survey on behalf of Delic Holdings, polling 2,037 adults ages 18 and older, 953 of whom suffer from anxiety/depression/PTSD The survey revealed that 65% of Americans living with anxiety/depression/PTSD believe that psychedelic medicine should be available to patients with treatment-resistant conditions 66%, 62%, and 56% are open to pursuing ketamine, psilocybin, and MDMA, respectively, to treat anxiety/depression/PTSD if these psychedelic drugs were each proven more effective than prescription medication with fewer side effects Though the U.S. government has not yet federally recognized a medical use for most psychedelic drugs, research by renowned universities and companies…

TuesdayJan 25, 2022 11:14 am

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Marks Significant Milestone in Pursuit of Berubicin Approval for Global GBM Treatment, Raises $11.5 Million from Private Placement

CNS Pharmaceuticals received approval from swissethics for its potentially pivotal study of Berubicin, a novel anthracycline for the treatment of Glioblastoma Multiforme (“GBM”) The approval is the first from a European Ethics Committee The company, which dosed the first patients in its Berubicin program in September, has selected multiple clinical sites across the U.S., Spain, France, Italy, and Switzerland CNS recently closed an $11.5 million private placement It intends to use the net proceeds to fund its clinical trials and preclinical programs, other R&D programs, and for general corporate purposes Clinical stage biotechnology company CNS Pharmaceuticals (NASDAQ: CNSP) is celebrating…

TuesdayJan 25, 2022 10:47 am

FuelPositive Corp. (TSX.V: NHHH) (OTCQB: NHHHF): a 2021 Overall Review

FuelPositive has hit multiple milestones throughout 2021, starting with its rebranding in January that ushered it into the world of green hydrogen and ammonia In March, the company acquired the intellectual property for its green ammonia production technology In May, FuelPositive began building its prototype production systems in collaboration with the National Compressed Air in Toronto and is on track to launch multiple real-world demonstration pilot projects throughout 2022 The modular, scalable green ammonia production systems offer numerous benefits, including zero carbon emissions and cheaper production costs than traditional grey ammonia production On January 19, 2021, shareholders, during the annual…

MondayJan 24, 2022 1:20 pm

Nemaura Medical Inc. (NASDAQ: NMRD) Commence Rollout of Their Miboko Application; Company Targets Employers & Insurers to Ensure Broad Commercial Distribution

Nemaura Medical is a medical technology company focused on developing non-invasive wearable diagnostic devices The company recently announced the rollout of its Miboko application by targeting insurers and employers In 2019, over $760 billion was spent on diabetes-related health care, equating to $9,000 per diabetic patient compared to $1,600 for a non-diabetic individual The Miboko application provides users with an efficient and accurate means of tracking their day-to-day glycaemic levels, a key determinant of overall metabolic health Nemaura Medical (NASDAQ: NMRD), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs,…

MondayJan 24, 2022 1:12 pm

Friendable Inc. (FDBL) Discloses Driving Factors Behind Acquisition of Artist Republik and Benefits to Fan Pass Live Artist Platform

Since Summer 2021, Friendable has been searching for the right music distribution platform to pair with its successful flagship offering, Fan Pass Live The acquisition of Artist Republik brings an additional 100,000 artists to the platform and an extensive tech deck that will benefit all parties The Artist Republik acquisition provides independent artists with access to a distribution offering, which they would not have unless they paid additional for management and were assigned to a record label Mobile technology and marketing company Friendable (OTC: FDBL) is releasing more details about the recent acquisition of Artist Republik, a reputable music distribution…

MondayJan 24, 2022 1:07 pm

StraightUp Resources Inc. (CSE: ST) (OTCQB: STUPF) Strengthens its Commitment to the Red Lake Mining District Following Approval of its Exploration Permit for RLX

StraightUp received its early exploration permit that allows it to begin exploration activities on the eastern block of its RLX North property The company will be taking a systematic approach to developing and testing gold targets as it plans to execute its 2022 work programs which will include drilling prospective targets in the summer This approval strengthens StraightUp’s commitment to the Red Lake Mining District, having expressed the intention to acquire 100% undivided interest in the RLX property back in September 2021 StraightUp also announced the appointment of Jacqueline Collins as the company’s new Corporate Secretary StraightUp Resources (CSE: ST)…

MondayJan 24, 2022 12:48 pm

Flora Growth Corp. (NASDAQ: FLGC) Kicks off 2022 with Successful First Cannabis Extraction at new Colombia Facility, the Appointment of Tim Leslie as Advisory Board Chairman, and 360 Financial Inc.’s FLGC stock purchase

Flora Growth just announced the production of its first batch of crude oil through its newly constructed facility in Colombia The company has also initiated the EU-GMP certification process that will allow it to target international medical cannabis markets Flora Growth also announced the appointment of Tim Leslie as Chairman of its newly established Advisory Board Mr. Leslie will play a key role in advising the company on how best to navigate the regulatory framework of building a truly global company 360 Financial, Inc. announced the purchase of 13,162 Flora Growth shares as of Q4 2021 Flora Growth (NASDAQ: FLGC)…

MondayJan 24, 2022 12:27 pm

Mydecine Innovations Group Inc.’s (NEO: MYCO) (OTC: MYCOF) Plans Program to Provide Resources for Safe, Effective Integration of Psychedelic-Assisted Psychotherapies into Existing Medical Practices

Mydecine plans to launch a program to provide products and services to healthcare professionals, clinics, and hospitals in Canada looking to treat patients through psychedelic-assisted psychotherapy The products and services, which will be available for purchase as a package, include cGMP psilocybin and MDMA, therapy manuals, investigative brochures, protocol training, advisory services, and post-therapy support The planned launch follows an amendment to federal regulations allowing physicians to request and prescribe restricted drugs for treatment-resistant patients Canada began the year on a high note by updating the Special Access Program (“SAP”), a move that demonstrates the government’s serious consideration of the…

Site Search

Company Search

Category: News